Article Details
Retrieved on: 2021-04-19 08:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Omeros has a cash-to-debt ratio of 0.50, which is worse than 89% of the companies in Biotechnology industry. GuruFocus ranks the overall financial ...
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here